|
1
|
Berner K, Bjerkehagen B, Bruland ØS and
Berner A: Extra skeletal osteosarcoma in Norway, between 1975 and
2009, and a brief review of the literature. Anticancer Res.
35:2129–2140. 2015.PubMed/NCBI
|
|
2
|
Glass R, Asirvatham JR, Kahn L and Aziz M:
Beta-human chorionic gonadotropin producing osteosarcoma of the
sacrum in a 26-year-old woman: A case report and review of the
literature. Case Rep Pathol. 2015:8972302015.PubMed/NCBI
|
|
3
|
Dell'Amore A, Asadi N, Caroli G, Dolci G,
Bini A and Stella F: Recurrent primary cardiac osteosarcoma: A case
report and literature review. Gen Thorac Cardiovasc Surg.
62:175–180. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Farcas N, Arzi B and Verstraete FJ: Oral
and maxillofacial osteosarcoma in dogs: A review. Vet Comp Oncol.
12:169–180. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kubo T, Shimose S, Fujimori J, Furuta T
and Ochi M: Quantitative (201)thallium scintigraphy for prediction
of histological response to neoadjuvant chemotherapy in
osteosarcoma; systematic review and meta-analysis. Surg Oncol.
24:194–199. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tabatabaei SH, Jahanshahi G and Dehghan
Marvasti F: Diagnostic challenges of low-grade central osteosarcoma
of jaw: A literature review. J Dent (Shiraz). 16:62–67.
2015.PubMed/NCBI
|
|
7
|
O'Kane GM, Cadoo KA, Walsh EM, Emerson R,
Dervan P, O'Keane C, Hurson B, O'Toole G, Dudeney S, Kavanagh E, et
al: Perioperative chemotherapy in the treatment of osteosarcoma: A
26-year single institution review. Clin Sarcoma Res. 5:172015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Szewczyk M, Lechowski R and Zabielska K:
What do we know about canine osteosarcoma treatment? Review. Vet
Res Commun. 39:61–67. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Friebele JC, Peck J, Pan X, Abdel-Rasoul M
and Mayerson JL: Osteosarcoma: A meta-analysis and review of the
literature. Am J Orthop (Belle Mead NJ). 44:547–553.
2015.PubMed/NCBI
|
|
10
|
Zhou Y, Zhao RH, Tseng KF, Li KP, Lu ZG,
Liu Y, Han K, Gan ZH, Lin SC, Hu HY and Min DL: Sirolimus induces
apoptosis and reverses multidrug resistance in human osteosarcoma
cells in vitro via increasing microRNA-34b expression. Acta
Pharmacol Sin. 37:519–529. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao H, Peng C, Ruan G, Zhou J, Li Y and
Hai Y: Adenovirus-delivered PDCD5 counteracts adriamycin resistance
of osteosarcoma cells through enhancing apoptosis and inhibiting
Pgp. Int J Clin Exp Med. 7:5429–5436. 2014.PubMed/NCBI
|
|
12
|
Tsai HC, Huang CY, Su HL and Tang CH: CCN2
enhances resistance to cisplatin-mediating cell apoptosis in human
osteosarcoma. PLoS One. 9:e901592014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
He H, Ni J and Huang J: Molecular
mechanisms of chemoresistance in osteosarcoma (Review). Oncol Lett.
7:1352–1362. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sharma G, Rana NK, Singh P, Dubey P,
Pandey DS and Koch B: p53 dependent apoptosis and cell cycle delay
induced by heteroleptic complexes in human cervical cancer cells.
Biomed Pharmacother. 88:218–231. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Locklin RM, Federici E, Espina B, Hulley
PA, Russell RG and Edwards CM: Selective targeting of death
receptor 5 circumvents resistance of MG-63 osteosarcoma cells to
TRAIL-induced apoptosis. Mol Cancer Ther. 6:3219–3228. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vourvouhaki E, Carvalho C and Aguiar P:
Model for Osteosarcoma-9 as a potent factor in cell survival and
resistance to apoptosis. Phys Rev E Stat Nonlin Soft Matter Phys.
76:0119262007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu X, Yang X, Xing C, Zhang S and Cao J:
miRNA: The nemesis of gastric cancer (Review). Oncol Lett.
6:631–641. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Banerjee N, Kim H, Krenek K, Talcott ST
and Mertens-Talcott SU: Mango polyphenolics suppressed tumor growth
in breast cancer xenografts in mice: Role of the PI3K/AKT pathway
and associated microRNAs. Nutr Res. 35:744–751. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bi C, Chung TH, Huang G, Zhou J, Yan J,
Ahmann GJ, Fonseca R and Chng WJ: Genome-wide pharmacologic
unmasking identifies tumor suppressive microRNAs in multiple
myeloma. Oncotarget. 6:26508–26518. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Igaz I and Igaz P: Are circulating
microRNAs involved in tumor surveillance? EXS. 106:269–280.
2015.PubMed/NCBI
|
|
21
|
Hou LJ and Zhai JJ: Aberrant expression
profile of translationally controlled tumor protein and
tumor-suppressive microRNAs in cervical cancer. J BUON.
20:1504–1509. 2015.PubMed/NCBI
|
|
22
|
Golestaneh AF, Atashi A, Langroudi L,
Shafiee A, Ghaemi N and Soleimani M: miRNAs expressed differently
in cancer stem cells and cancer cells of human gastric cancer cell
line MKN-45. Cell Biochem Funct. 30:411–418. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mongre RK, Sodhi SS, Ghosh M, Kim JH, Kim
N, Sharma N and Jeong DK: A new paradigm to mitigate osteosarcoma
by regulation of MicroRNAs and suppression of the NF-κB signaling
cascade. Dev Reprod. 18:197–212. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sampson VB, Yoo S, Kumar A, Vetter NS and
Kolb EA: MicroRNAs and potential targets in osteosarcoma: Review.
Front Pediatr. 3:692015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chang L, Shrestha S, LaChaud G, Scott MA
and James AW: Review of microRNA in osteosarcoma and
chondrosarcoma. Med Oncol. 32:6132015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mason TJ and Matthews M: Aquatic
environment, housing, and management in the eighth edition of the
guide for the care and use of laboratory animals: Additional
considerations and recommendations. J Am Assoc Lab Anim Sci.
51:329–332. 2012.PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhuang T, Djemil T, Qi P, Magnelli A,
Stephans K, Videtic G and Xia P: Dose calculation differences
between Monte Carlo and pencil beam depend on the tumor locations
and volumes for lung stereotactic body radiation therapy. J Appl
Clin Med Phys. 14:40112013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yin Z, Ding H, He E, Chen J and Li M:
Up-regulation of microRNA-491-5p suppresses cell proliferation and
promotes apoptosis by targeting FOXP4 in human osteosarcoma. Cell
Prolif. 50:2017. View Article : Google Scholar
|
|
30
|
Zhou Y, Yang C, Wang K, Liu X and Liu Q:
MicroRNA-33b inhibits the proliferation and migration of
osteosarcoma cells via targeting hypoxia-inducible factor-1α. Oncol
Res. 25:397–405. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhi X, Wu K, Yu D, Wang Y, Yu Y, Yan P and
Lv G: MicroRNA-494 inhibits proliferation and metastasis of
osteosarcoma through repressing insulin receptor substrate-1. Am J
Transl Res. 8:3439–3447. 2016.PubMed/NCBI
|
|
32
|
Azam AT, Bahador R, Hesarikia H, Shakeri M
and Yeganeh A: Retraction Note to: Downregulation of microRNA-217
and microRNA-646 acts as potential predictor biomarkers in
progression, metastasis, and unfavorable prognosis of human
osteosarcoma. Tumour Biol. Nov 5–2016.(Epub ahead of print).
View Article : Google Scholar
|
|
33
|
Taheriazam A, Bahador R, Karbasy SH,
Jamshidi SM, Torkaman A, Yahaghi E and Shakeri M: Retraction note:
Down-regulation of microRNA-26a and up-regulation of microRNA-27a
contributes to aggressive progression of human osteosarcoma. Diagn
Pathol. 11:1112016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kovács D, Igaz N, Keskeny C, Bélteky P,
Tóth T, Gáspár R, Madarász D, Rázga Z, Kónya Z, Boros IM and
Kiricsi M: Silver nanoparticles defeat p53-positive and
p53-negative osteosarcoma cells by triggering mitochondrial stress
and apoptosis. Sci Rep. 6:279022016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang H, Zhang T, Sun W, Wang Z, Zuo D,
Zhou Z, Li S, Xu J, Yin F, Hua Y and Cai Z: Erianin induces
G2/M-phase arrest, apoptosis, and autophagy via the ROS/JNK
signaling pathway in human osteosarcoma cells in vitro and in vivo.
Cell Death Dis. 7:e22472016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chinchar E, Makey KL, Gibson J, Chen F,
Cole SA, Megason GC, Vijayakumar S, Miele L and Gu JW: Sunitinib
significantly suppresses the proliferation, migration, apoptosis
resistance, tumor angiogenesis and growth of triple-negative breast
cancers but increases breast cancer stem cells. Vasc Cell.
6:122014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Guidicelli G, Chaigne-Delalande B,
Dilhuydy MS, Pinson B, Mahfouf W, Pasquet JM, Mahon FX, Pourquier
P, Moreau JF and Legembre P: The necrotic signal induced by
mycophenolic acid overcomes apoptosis-resistance in tumor cells.
PLoS One. 4:e54932009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Han J, Tian R, Yong B, Luo C, Tan P, Shen
J and Peng T: Gas6/Axl mediates tumor cell apoptosis, migration and
invasion and predicts the clinical outcome of osteosarcoma
patients. Biochem Biophys Res Commun. 435:493–500. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kushlinskii NE, Solov'ev YN, Babkina IV,
Abbasova SG, Kostanyan IA, Lipkin VM and Trapeznikov NN: Leptin and
apoptosis inhibitor soluble Fas antigen in the serum of patients
with osteosarcoma and neuroectodermal bone tumors. Bull Exp Biol
Med. 129:496–498. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xie C, Han Y, Liu Y, Han L and Liu J:
miRNA-124 down-regulates SOX8 expression and suppresses cell
proliferation in non-small cell lung cancer. Int J Clin Exp Pathol.
7:6534–6542. 2014.PubMed/NCBI
|
|
41
|
Polimeni M, Gulino GR, Gazzano E, Kopecka
J, Marucco A, Fenoglio I, Cesano F, Campagnolo L, Magrini A,
Pietroiusti A, et al: Multi-walled carbon nanotubes directly induce
epithelial-mesenchymal transition in human bronchial epithelial
cells via the TGF-β-mediated Akt/GSK-3β/SNAIL-1 signalling pathway.
Part Fibre Toxicol. 13:272016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang L, Kang FB, Sun N, Wang J, Chen W, Li
D and Shan BE: The tumor suppressor miR-124 inhibits cell
proliferation and invasion by targeting B7-H3 in osteosarcoma.
Tumour Biol. 37:14939–14947. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Geng S, Zhang X, Chen J, Liu X, Zhang H,
Xu X, Ma Y, Li B, Zhang Y, Bi Z and Yang C: The tumor suppressor
role of miR-124 in osteosarcoma. PLoS One. 9:e915662014. View Article : Google Scholar : PubMed/NCBI
|
